钙通道阻滞剂在高血压治疗中的临床价值

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)[J] . Morris J Brown,Christopher R Palmer,Alain Castaigne,Peter W de Leeuw,Giuseppe Mancia,Talma Rosenthal,Luis M Ruilope.The Lancet . 2000 (9227)

Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study[J] . The Lancet . 2000 (9227)

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study[J] . The Lancet . 1999 (9192)

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial[J] . The Lancet . 1998 (9118)

Morbidity and mortality in patients randomised to double-blind treatment with a long-acting calcium-channel blocker or diuretic in the International Nifedipine GITS study: Intervention as a Goal in Hypertension Treatment (INSIGHT)[J] . Morris J Brown,Christopher R Palmer,Alain Castaigne,Peter W de Leeuw,Giuseppe Mancia,Talma Rosenthal,Luis M Ruilope.The Lancet . 2000 (9227)

Randomised trial of effects of calcium antagonists compared with diuretics and β-blockers on cardiovascular morbidity and mortality in hypertension: the Nordic Diltiazem (NORDIL) study[J] . The Lancet . 2000 (9227)

Randomised trial of old and new antihypertensive drugs in elderly patients: cardiovascular mortality and morbidity the Swedish Trial in Old Patients with Hypertension-2 study[J] . The Lancet . 1999 (9192)

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial[J] . The Lancet . 1998 (9118)